Articolo in rivista, 2023, ENG, 10.3389/fendo.2023.1135157
De Filippo, Carlotta; Costa, Alessia; Becagli, Maria Vittoria; Monroy, Mariela Mejia; Provensi, Gustavo; Passani, Maria Beatrice
Istituto di Biologia e Biotecnologia Agraria, Consiglio Nazionale delle Ricerche (IBBA CNR); Università degli Studi di Firenze
A vast literature strongly suggests that the endocannabinoid (eCB) system and related bioactive lipids (the paracannabinoid system) contribute to numerous physiological processes and are involved in pathological conditions such as obesity, type 2 diabetes, and intestinal inflammation. The gut paracannabinoid system exerts a prominent role in gut physiology as it affects motility, permeability, and inflammatory responses. Another important player in the regulation of host metabolism is the intestinal microbiota, as microorganisms are indispensable to protect the intestine against exogenous pathogens and potentially harmful resident microorganisms. In turn, the composition of the microbiota is regulated by intestinal immune responses. The intestinal microbial community plays a fundamental role in the development of the innate immune system and is essential in shaping adaptive immunity. The active interplay between microbiota and paracannabinoids is beginning to appear as potent regulatory system of the gastrointestinal homeostasis. In this context, oleoylethanolamide (OEA), a key component of the physiological systems involved in the regulation of dietary fat consumption, energy homeostasis, intestinal motility, and a key factor in modulating eating behavior, is a less studied lipid mediator. In the small intestine namely duodenum and jejunum, levels of OEA change according to the nutrient status as they decrease during food deprivation and increase upon refeeding. Recently, we and others showed that OEA treatment in rodents protects against inflammatory events and changes the intestinal microbiota composition. In this review, we briefly define the role of OEA and of the gut microbiota in intestinal homeostasis and recapitulate recent findings suggesting an interplay between OEA and the intestinal microorganisms.
Frontiers in endocrinology (Lausanne) 14 (1135157)
dysbiosis, gut barrier permeability, inflammation, intestinal physiology, metabolic diseases, obesity
ID: 490618
Year: 2023
Type: Articolo in rivista
Creation: 2023-12-23 18:05:02.000
Last update: 2023-12-27 20:06:05.000
CNR authors
CNR institutes
External links
OAI-PMH: Dublin Core
OAI-PMH: Mods
OAI-PMH: RDF
DOI: 10.3389/fendo.2023.1135157
URL: http://www.scopus.com/record/display.url?eid=2-s2.0-85153489983&origin=inward
External IDs
CNR OAI-PMH: oai:it.cnr:prodotti:490618
DOI: 10.3389/fendo.2023.1135157
Scopus: 2-s2.0-85153489983